Table 4.

Odds Ratios (ORs) for Left Ventricular Hypertrophy (n = 498)

Variable	Unadjusted			Adjusted
	OR	95% CI	P Value	OR	95% CI	Wald χ (2)	P Value
Proximal CD4 count < 200 cells/mm3	1.38	0.92–2.08	.12	1.68	1.08–2.62	5.26	.02
CD4 nadir < 200 cells/mm3	1.46	0.96–2.22	.11	1.63	1.04–2.54	4.60	.03
VL (most recent) < 400 copies/mL	0.56	0.35–0.89	.02	0.46	0.27–0.80	7.48	.006
Abacavir exposure	0.73	0.44–1.21	.22	0.74	0.43–1.30	1.09	.30
Didanosine/stavudine exposure	1.05	0.68–1.63	.82	1.17	0.72–1.89	0.38	.54
Zidovudine exposure	1.10	0.73–1.67	.89	1.17	0.75–1.83	0.47	.79
PI exposure Continuous proximal CD4 count	0.87	0.59–1.28	.48	0.83	0.53–1.33	0.59	.44
per 1-cell/mm3 decrease	1.001	1.00–1.001	.07	1.001	1.00–1.002	4.75	.03
per 50-cell/mm3 decrease	1.03	1.00–1.06		1.04	1.00–1.09
Continuous nadir CD4
per 1-cell/mm3 decrease	1.001	1.00–1.002	.05	1.002	1.00–1.003	5.97	.02
per 50-cell/mm3 decrease	1.06	1.00–1.12		1.09	1.02–1.14

CI, confidence interval; PI, protease inhibitor; VL, viral load.